(PharmaNewsWire.Com, December 15, 2017 ) The Global Unnatural Amino Acids Market report titled “Unnatural Amino Acids Market Research Report-Forecast to 2023″ is a specialist investigation report by Market Research Future includes broad essential research alongside the definite examination of subjective and additionally quantitative perspectives by different industry specialists, key sentiment pioneers to pick up a more profound understanding of the market and industry execution. The global unnatural amino acids market is expected to grow at a CAGR of 7.4% during the forecast period 2017-2023.
Market Research Future published new report, titled “Unnatural Amino Acids Market -Research Report: Global Forecast till 2023”.
Market Highlights of the Global Unnatural Amino Acids Market:
Unnatural amino acids are a chemically synthesized or naturally occurring non-proteinogenic amino acids. A large number of amino acid derivatives are used as building blocks or primary ingredients for a number of pharmaceutical compounds, which act as molecular scaffolds in various pharmaceutical products. They are molecular scaffolds or pharmacologically active products and have diverse structural elements that lead to the development of new peptide and non-peptide compounds having a number of applications in the chemical industry as well as pharmaceuticals industry.
Increasing demand for unnatural amino acids for the development of finished pharmaceutical products, increasing research and development activities in pharmaceuticals and manufacturing of active pharmaceutical industry drive the growth of the market.
Additionally, high healthcare expenditure, increasing demand for the better treatment, and rising number of patients suffering from chronic diseases such as liver diseases, and inflammatory diseases are likely to provide support for the growth of the market. However, increasing competition among existing market players acts as a barrier for the entry of new players in the market.
Key Players in Global Unnatural Amino Acids Market:
Some of key the players in the market are Merck KGaA (Germany), CordenPharma International (Germany), YONEYAMA YAKUHIN KOGYO CO.,LTD. (Japan), Sekisui XenoTech, LLC. (U.S.) , Varsal (U.S.), Biosyn (U.S.), NAGASE & CO., LTD. (Japan), Kyowa Hakko Europe GmbH, AbbVie, Inc. (U.S.), Ajinomoto Co., Inc. (Japan), AminoLogics Co. Ltd. (South Korea), AnaSpec, Inc. (U.S.), BASF SE (Germany), Biological E Ltd. (India), C-TRI Co., Ltd. (South Korea), and Evonik Industries AG (Germany), Divis Laboratories Ltd. (India), Donboo Amino Acid Co., Ltd. (China), DSM Sinochem Pharmaceuticals (Singapore), EMD Millipore (USA), Enzo Life Sciences, Inc. (USA), Evonik Industries AG (Germany), GlaxoSmithKline plc (U.K), Novartis AG (Switzerland), Pfizer, Inc. (the USA), Ranbaxy Laboratories Ltd. (India), and Sanofi (France).
Market Segments:
The global unnatural amino acids market is segmented on the basis of types, indication, and end users.
On the basis of THE types, the market is segmented into non-alpha, D-Amino Acids, L-Amino Acid, and others. The non-alpha type is further segmented into ß-amino acids, ß-amino acid derivatives, γ-aminobutyric acid, and others. D-Amino Acids is further segmented into D-alanine, D-glutamate, and others.
On the basis of the indication, the market is segmented into liver diseases, cancer, genetic diseases, inflammatory disease, and others.
On the basis of the end users, the market is segmented into pharmaceutical & biotechnological companies, hospital & clinics, academic institutes, and others.
The Americas account for the major share of the global unnatural amino acids market owing to the increasing number of patients with liver diseases, well-developed technology, and increasing government support for research & development. Additionally, growing demand for amino acid derivatives for the production of pharmaceutical products along with rising healthcare expenditure and changing lifestyle have fuelled the growth of the Americas unnatural amino acids market. According to the International Monetary Fund (IMF), The U.S. economy grew in 2016 by 1.6% in 2016. In 2017, due to change in the regulatory policies, the R&D investment is affected a lot. In 2016, R&D spending of US was 527.5 billion. The increase of insurance coverage because of health care reform (Affordable Care Act, 2010) in the U. S. additionally prompted an expansion of health care spending.
Europe is the second largest unnatural amino acids market, which is followed by Asia Pacific. Germany and the U.K are the major contributors to the market. The European market is governed by the increasing demand for pharmaceutical products in Germany, the U.K, and France.
Asia Pacific is the fastest growing unnatural amino acids market owing to the presence of rapidly developing economy, increasing the prevalence of chronic diseases such as liver diseases, cancer, inflammatory diseases, and emphasis on the use of active pharmaceuticals and development of the pharmaceutical industry.
On the other hand, the Middle East & Africa hold the least share of the market due to poor healthcare infrastructure in Africa and limited availability of funds and medical facilities. The Middle East market is driven by increasing prevalence of chronic disease, lack of physical exercise, and others. Development of healthcare industry in the Middle East & Africa also fuels the growth of the market.
Major Table Contents:
Chapter 1. Report Prologue
Chapter 2. Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Creatinine Test Market, By Type
Chapter 7. Global Unnatural Amino Acids Market, By Indication
Chapter 8. Global Unnatural Amino Acids Market, By End User
Chapter 9. Global Unnatural Amino Acids Market, By Region
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
